According to a 2017 report from Deloitte, biopharma R&D returns have declined to 3.2%, down from 10.1% in 2010. This decline in returns is driven by the combination of an increase in the cost to bring a drug to market (now estimated at nearly $2bn USD) and a decline in projected peak sales per asset. LabCorp’s PharmAcuity product suite is designed to help pharma companies reduce cycle times and lower costs, leading to an improvement in R&D productivity.
By attending this webinar, companies will gain insight into the benefits of using PharmAcuity, such as:
- Optimizing your clinical trial strategy, planning, and design before a given trial begins
- Enabling you to analyze and evaluate your clinical trial performance versus the rest of the pharma industry
- Identifying “known” and “new” high/low performing countries
- Setting ambitious but feasible targets for particular study milestones
- Increasing the percentage of the highest-performing sites via country selection
The proprietary, industry-leading clinical trial performance data in PharmAcuity includes over 10,000 past and ongoing trials. In addition, the data is truly global, with performance data from over 100 countries. The Metrics & Benchmarking application offers 14 key performance indicators (KPIs) and 16 filters, providing an unmatched level of depth, breadth, and customization.
Enrolment rate, time to activate a given percentage of sites, time to enrol a given percentage of patients, and proportion of non-low-high performing sites are just a few examples from all the KPIs that are currently available. Filter options include common search criteria such as therapeutic area, indication, and phase, as well as highly-detailed criteria such as biomarkers / driver mutations, line of therapy, country, and disease stage.
To learn more about the benefits of utilizing this tool to analyse and improve your clinical trial performance, register for this webinar, Optimizing Your Clinical Trial Performance Through Metrics and Benchmarking.
Krish Ghosh, Ph.D., MBA,
VP, Informatics
Krish is the Vice President of Informatics at LabCorp. He is responsible for overseeing PharmAcuity, LabCorp’s cloud-based software-as-a-service (SaaS) product, which leverages proprietary and public data to provide insights and guide decision-making in the pharmaceutical industry. Previously, Krish was the Vice President of Informatics and Vice President of Global Resource Management at Covance, where he developed many innovative solutions.
Before joining Covance in 2006, Krish worked for 13 years in the pharmaceutical industry and four years in academia. He was the Director of Project Planning and Information at Wyeth Pharmaceuticals Inc., and held different positions in research and development at Bristol-Myers Squibb Co. Krish holds a Master of Business Administration in finance and a doctorate in statistics from Temple University.
Eric Sabo, MBA,
Director, Product Management
Eric is the Product Manager for PharmAcuity, a SaaS analytics application that helps pharmaceutical companies improve clinical trial planning and design. As the Product Manager, he manages client relationships, leads a team of software developers, defines and prioritizes the product roadmap, and leads contracting and pricing negotiations.
Previously, Eric worked on clinical trial optimization software at Quintiles Transnational Corp. He has a Bachelor of Science in biomedical engineering from UNC Chapel Hill and a Master of Business Administration from Duke University’s Fuqua School of Business.
- Setting ambitious but feasible targets for future study milestones using data-driven insights
- Increasing the percentage of the highest-performing sites via country selection
- Understanding what worked and what didn’t from past trials, and incorporating the lessons learned into future trials
- Analytics
- Strategic Analytics
- Informatics
- Resource Management
- Clinical Planning
- Clinical Operations
- Pipeline Business Development
- R&D Pipeline Planning
- Site Selection
- Country Selection
